A Clinical Radiomics Nomogram Was Developed by Integrating Radiomics Signatures and Clinical Variables to Distinguish High-Grade ccRCC from Type 2 pRCC

<div>A radiomics nomogram distinguishing between high-grade clear cell renal cell carcinoma (ccRCC) and type 2 papillary renal cell carcinoma (pRCC). Based on a training cohort, the nomogram was created by combining the relative enhancement value of the corticomedullary phase (REV1) and radiomics score (Rad-score).</div>

Journal of Oncology

fig4

Figure 4

Figure 4: A Clinical Radiomics Nomogram Was Developed by Integrating Radiomics Signatures and Clinical Variables to Distinguish High-Grade ccRCC from Type 2 pRCC 

Figure 4 | A Clinical Radiomics Nomogram Was Developed by Integrating Radiomics Signatures and Clinical Variables to Distinguish High-Grade ccRCC from Type 2 pRCC 